Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01099852Unknown

Cohort of Patients Infected by an Arbovirus

Role: collaborator

NCT02000635Unknown

Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique

Role: collaborator

NCT01104740Completed

Dengue Seroprevalence Study in Blood Donors in the French West Indies

Role: collaborator

NCT01607047Unknown

French West Indies Leptospirosis Study

Role: collaborator

NCT01226368Completed

Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.

Role: collaborator

NCT01264809Not ApplicableUnknown

Exercise Consultation for Type 2 Diabetes Patients in Real Life

Role: collaborator

All 6 trials loaded